PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase

RALEIGH, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced the pricing of the previously announced secondary offering of shares of its common stock.  KKR PRA Investors L.P. (the “Selling Stockholder”), has agreed to sell an aggregate of 6,666,684 shares of the Company’s common stock in an […]

Read more

PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share Repurchase

RALEIGH, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that KKR PRA Investors L.P. (the “Selling Stockholder”), intends to offer for sale in an underwritten secondary offering 6,666,684 shares of common stock of the Company pursuant to the Company’s shelf registration statement filed with the Securities […]

Read more